Author
Listed:
- D. Kalaiarasan
(Government College of Engineering Srirangam)
- R. Murugasami
(Nandha Engineering College)
- Tammineni Sreelatha
(Koneru Lakshmaiah Education Foundation)
- E. Mohan
(SIMATS)
Abstract
The application of machine learning and internet of things (IoT) technologies in medical settings has dramatically altered the landscape of leukemic cell research, diagnosis, and treatment. This technological integration has ushered in a new era in the field of leukemia management, significantly enhancing our ability to detect, comprehend, and address malignant cells. This novel approach has transformed the landscape of both leukemia research and patient management. Feature selection of leukemic cells through a classification process using IoT and machine learning represents a great opportunity where both promise and challenges have been faced towards the medical field. This study is aimed at developing a new system to guide the application of technologies for precise identification of leukemic cells. The system employs several feature-selection and classification techniques based on a cell sample analysis of the patients. Because the system for analyzing a large number of medical and biological samples is new and bring the ground baseline for the medical clinicians so that they can discover and develop the algorithms for understanding leukemia and other disease. A hybrid that consists of an SVM algorithm for classifying and CNN model for extracting general features also did brilliantly. It selects features through different machine learning algorithms to identify a minimal feature set that is effective in differentiating high quality cells with high accuracy and precision. A classification model approach was then taken by using list of features to classify cell types by their features. The analysis of neural networks was conducted using the clinically established ALL-IDB, a collection of micrographic blood image sample images that are freely available on the internet. As many existing methods were available, results of the proposed model were compared with gray wolf optimization (GWO), enhanced machine learning (EML) and feature selection-enabled machine learning (FSEML). On 100 samples, the positive predictive value of the proposed model was 95.40%, which is better than GWO (47.82%), EML (89.40%), and FSEML (84.88%).
Suggested Citation
D. Kalaiarasan & R. Murugasami & Tammineni Sreelatha & E. Mohan, 2025.
"A novel leukemic cells feature selection using convolutional neural networks and classification using machine learning algorithms,"
International Journal of System Assurance Engineering and Management, Springer;The Society for Reliability, Engineering Quality and Operations Management (SREQOM),India, and Division of Operation and Maintenance, Lulea University of Technology, Sweden, vol. 16(11), pages 3547-3561, November.
Handle:
RePEc:spr:ijsaem:v:16:y:2025:i:11:d:10.1007_s13198-025-02843-z
DOI: 10.1007/s13198-025-02843-z
Download full text from publisher
As the access to this document is restricted, you may want to
for a different version of it.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:ijsaem:v:16:y:2025:i:11:d:10.1007_s13198-025-02843-z. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.